ACTA1 and neoplasm: It was also shown that the drug causes changes in the TME, which may contribute to the antitumor effect, including an increase in tumor-associated macrophages (adopting an M1-like phenotype) and αSMA+ myofibroblasts (types of cells known for their tumor-inhibitory properties).